It has been reported that LHX6 expression is decreased in lung cancer,21 head and neck cancer,22 breast cancer,23 and liver cancer24 through epigenetic inactivation, indicating that it could be a sensitive biomarker for that cancer. Here, LHX6 is linked to cancer.